April 16, 2020
A class of experimental cancer drugs called BET inhibitors have shown promise for treating cancers of the blood but can induce toxic side effects. Now Yale researchers have found a new inhibitor that in animal studies demonstrates greater potency against a wider variety of cancers, as well as against solid […]